MA27006A1 - Compositions virocides. - Google Patents

Compositions virocides.

Info

Publication number
MA27006A1
MA27006A1 MA27326A MA27326A MA27006A1 MA 27006 A1 MA27006 A1 MA 27006A1 MA 27326 A MA27326 A MA 27326A MA 27326 A MA27326 A MA 27326A MA 27006 A1 MA27006 A1 MA 27006A1
Authority
MA
Morocco
Prior art keywords
virocidal
compositions
viruses
composition
effective
Prior art date
Application number
MA27326A
Other languages
English (en)
Inventor
Thomas W Konowalchuk
Jack Konowalchuk
Original Assignee
Thomas W Konowalchuk
Jack Konowalchuk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/795,279 external-priority patent/US7399790B2/en
Application filed by Thomas W Konowalchuk, Jack Konowalchuk filed Critical Thomas W Konowalchuk
Publication of MA27006A1 publication Critical patent/MA27006A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

COMPOSITIONS VIROCIDES Procédé d'inactivation de virus comprenant la mise en contact du virus avec une quantité efficace au niveau virocide d'une composition constituée essentiellement d'un alcool monohydroxy en Cl à C3 ou d'un diol en C2 à C4 et d'une quantité suffisante d'un acide afin d'ajuster le pH de la composition en dessous de 4,6. L'administration topique de la composition est préférée et est efficace pour traiter des lésions associées aux infections par des virus telles que l'herpès simplex. Les formes pouvant être délivrées par voie nasale sont efficaces pour traiter les symptômes causés par les virus à l'origine du rhume. Des compositions pharmaceutiques à utiliser dans le présent procédé sont proposées.
MA27326A 2001-02-28 2003-09-26 Compositions virocides. MA27006A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/795,279 US7399790B2 (en) 2001-02-28 2001-02-28 Virucidal compositions
US10/016,189 US7045548B2 (en) 2001-02-28 2001-12-06 Methods of inactivating viruses
US10/021,533 US7268163B2 (en) 2001-02-28 2001-12-06 Method for treating an inflammation or lesion caused by a virus
US10/016,282 US7902258B2 (en) 2001-02-28 2001-12-06 Methods for preventing lesions caused by viruses of the Herpesviridae or Poxviridae family

Publications (1)

Publication Number Publication Date
MA27006A1 true MA27006A1 (fr) 2004-12-20

Family

ID=27486551

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27326A MA27006A1 (fr) 2001-02-28 2003-09-26 Compositions virocides.

Country Status (15)

Country Link
EP (1) EP1372389B1 (fr)
JP (1) JP2004529889A (fr)
CN (1) CN1264513C (fr)
AU (1) AU2002251933B2 (fr)
BR (1) BR0207703A (fr)
CA (1) CA2439413C (fr)
EA (1) EA005917B1 (fr)
IL (1) IL157596A0 (fr)
IS (1) IS2860B (fr)
MA (1) MA27006A1 (fr)
MX (1) MXPA03007748A (fr)
NO (1) NO333867B1 (fr)
NZ (1) NZ527931A (fr)
PL (1) PL365700A1 (fr)
WO (1) WO2002069887A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7399790B2 (en) 2001-02-28 2008-07-15 Konowalchuk Thomas W Virucidal compositions
DK2471559T3 (en) * 2006-02-09 2015-01-12 Gojo Ind Inc Antiviral method
US20070274926A1 (en) * 2006-05-26 2007-11-29 The Dial Corporation Method of inhibiting the transmission of viruses
CA2653380A1 (fr) 2006-05-30 2007-12-13 The Dial Corporation Compositions ayant une efficacite antivirale elevee
WO2008036134A2 (fr) * 2006-06-02 2008-03-27 The Dial Corporation Méthode destinée à inhiber la transmission du virus influenza
BRPI0622061B8 (pt) 2006-10-23 2021-05-25 Ecolab Inc composição viricida, uso e produto compreendendo a mesma
JP5542682B2 (ja) * 2008-10-24 2014-07-09 Ｍｃフードスペシャリティーズ株式会社 カリシウイルス不活化方法
WO2010082587A1 (fr) * 2009-01-13 2010-07-22 株式会社大気倶楽部 Adsorbant pour suspension dans l'air
EP2512231B1 (fr) 2009-12-16 2016-12-07 Ecolab Inc. Composition de gel pour la désinfection de la peau des mammiferes
WO2014062892A1 (fr) * 2012-10-19 2014-04-24 Flutrends International, Llc Compositions antivirales
FR3033576B1 (fr) * 2015-03-13 2018-11-16 Fondation Mediterranee Infection Methode d'inactivation d'un agent infectieux dans un echantillon biologique
WO2018130072A1 (fr) * 2017-01-12 2018-07-19 厦门大学 Méthode de stabilisation de la protéine de fusion du virus respiratoire syncytial
KR20190102898A (ko) * 2018-02-27 2019-09-04 지에스칼텍스 주식회사 2,3-부탄디올을 유효성분으로 포함하는 조성물
EP3937920B1 (fr) * 2019-03-14 2025-07-09 The Regents of the University of California Compositions comprenant du bêta-hydroxybutyrate et du citrate pour la prise en charge de la santé rénale
WO2025018263A1 (fr) * 2023-07-14 2025-01-23 イビデン株式会社 Composition et composition de matière de départ de produit cosmétique
WO2025018264A1 (fr) * 2023-07-14 2025-01-23 イビデン株式会社 Composition, composition de matière première de produit cosmétique, agent de suppression de prolifération virale, utilisation de la composition de suppression de prolifération virale, procédé de suppression de prolifération virale et corps scellé

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975217A (en) * 1981-07-20 1990-12-04 Kimberly-Clark Corporation Virucidal composition, the method of use and the product therefor
US4647458A (en) * 1981-09-25 1987-03-03 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Liquid bactericide for foods and food processing machines or utensils, employing a synergistic mixture of ethyl alcohol, an organic acid and phosphoric acid
CA1221640A (fr) * 1984-03-07 1987-05-12 Nicola Pamukoff Composes pharmaceutiques pour le traitement des infections virales
GB8604986D0 (en) * 1986-02-28 1986-04-09 Unilever Plc Disinfectant compositions
DE3622089A1 (de) * 1986-07-02 1988-01-07 Krueger Gmbh & Co Kg Viruzides mittel mit breitbandwirkung
US5405602A (en) * 1989-01-31 1995-04-11 Simmons; Paul L. Nonaqueous cold sterilant
US6034133A (en) * 1993-11-05 2000-03-07 The University Of Virginia Patents Foundation Use of a virucidal hand lotion to prevent the spread of rhinovirus colds
US6350724B1 (en) * 1999-04-20 2002-02-26 Effcon Laboratories, Inc. Lice removing composition

Also Published As

Publication number Publication date
NO20033829D0 (no) 2003-08-28
EP1372389A2 (fr) 2004-01-02
IS2860B (is) 2013-12-15
WO2002069887A3 (fr) 2003-01-09
NO333867B1 (no) 2013-10-07
EA200300843A1 (ru) 2004-06-24
CN1264513C (zh) 2006-07-19
CA2439413C (fr) 2017-01-03
PL365700A1 (en) 2005-01-10
CN1505478A (zh) 2004-06-16
IL157596A0 (en) 2004-03-28
NZ527931A (en) 2006-02-24
JP2004529889A (ja) 2004-09-30
EP1372389B1 (fr) 2011-10-05
IS6933A (is) 2003-08-27
NO20033829L (no) 2003-10-27
EP1372389A4 (fr) 2004-03-31
BR0207703A (pt) 2004-10-05
EA005917B1 (ru) 2005-06-30
MXPA03007748A (es) 2004-03-16
AU2002251933B2 (en) 2008-01-17
WO2002069887A2 (fr) 2002-09-12
CA2439413A1 (fr) 2002-09-12

Similar Documents

Publication Publication Date Title
MA27006A1 (fr) Compositions virocides.
BE1006233A3 (fr) Composition pour application nasale.
KR920021139A (ko) 약학 조성물
IL120317A0 (en) Otic antibacterial compositions
RU93053493A (ru) Сульфатная соль (2:1)-3-[2-(диметиламино)этил]-n-метил-1н-индол-5-метансульфонамида и ее фармацевтически приемлемые сольваты, способ их получения, фармацевтические композиции на их основе, их применение в терапии, способ лечения головной боли
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
RU2009149687A (ru) Фармацевтические композиции и способы лечения сухих кератитов
AU2012215383B2 (en) Novel antifungal composition
CN1173820A (zh) 治疗疱疹的药物组合物
ATE457177T1 (de) Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe
HRP20130071T1 (hr) Poboljšani testosteron u gelu i naäśin primjene
CA2377024A1 (fr) Composition ophthalmique
NO20002798L (no) Sammensetninger og metoder for Õ øke konsentrasjonen og/eller bevegeligheten av spermatozoa hos mennesker
NO20043001D0 (no) Farmasoytisk formulering omfattende cyklosporin og anvendelse derav
RU2004102395A (ru) Жидкая композиция, включающая сложный эфир полиоксиэтиленсорбита и жирной кислоты
JPH0912452A (ja) ジクロフェナクナトリウム含有乳化外用剤
JP2002510653A5 (fr)
EP2343038A1 (fr) Compositions dermatologiques contenant une association de lipides peroxydés et de zinc et leurs utilisations notamment dans le traitement de l'herpès
JP2002104959A (ja) 眼科用組成物
HUP0203050A2 (hu) Endometriózis és meddőség kezelésére, valamint a termékenység fokozására alkalmas gyógyszerkészítmények
JPH07277988A (ja) 局所用掻痒除去、治療剤
FI974444A0 (fi) N-hydroksiureayhdisteitä anti-inflammatorisina aineina
MA27474A1 (fr) Vaccin
MA27662A1 (fr) Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
AU2904700A (en) Pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and protozoa